MARIMED INC. MRMD
OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2012-05-04
MARIMED INC. statistics & valuation
Market cap$28.0M
P / S0.2×
P / B0.6×
P / FCF4.3×
Net margin-9.1%
Return on equity-29.0%
FCF margin4.1%
Net debt$76.0M
Net debt / EBITDA14.4×
Enterprise value USD$104.0M
EV / EBITDA19.7×
Earnings yield EBIT/EV-2.7%
Return on capital-2%
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 36.2% | 39.7% | 44.4% | 47.7% | 54.6% | 61.5% | 41.0% | 65.9% | 63.9% | 54.6% |
| Operating margin | -1.8% | 1.7% | 9.7% | 15.2% | 22.1% | 28.6% | -91.1% | -45.2% | 2.1% | 21.8% |
| Net margin | -9.1% | -7.9% | -10.8% | 10.0% | 5.9% | 4.2% | -178.0% | -114.8% | -19.7% | -5.6% |
| FCF margin | 4.1% | -3.3% | -8.2% | -3.6% | 14.8% | -2.6% | -74.1% | -99.8% | -316.6% | -99.9% |
| Return on assets | -7.2% | -6.0% | -8.2% | 8.8% | 5.9% | 2.8% | -131.9% | -16.4% | -3.7% | -2.3% |
| Return on equity | -29.0% | -21.3% | -23.3% | 23.5% | 19.9% | 26.5% | -1282.9% | -22.0% | -10.8% | 36.1% |
| Debt / equity | 1.52× | 1.34× | — | — | — | 4.53× | 5.73× | 0.35× | — | — |
| Current ratio | 1.00 | 1.07 | 1.67 | 1.67 | 1.64 | 0.91 | 0.20 | 1.58 | 0.32 | 0.40 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.